Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BeiGene Ltd ( (HK:6160) ) has issued an update.
BeOne Medicines Ltd. has announced a new offering period for its 2018 Employee Share Purchase Plan (ESPP), which allows eligible employees to purchase shares at a 15% discount to the market price. The offering period runs from September 2, 2025, to February 27, 2026, with 4,693 employees participating. This initiative is part of the company’s strategy to enhance employee engagement and align their interests with the company’s performance, although it does not include performance targets or a clawback mechanism.
The most recent analyst rating on (HK:6160) stock is a Hold with a HK$200.00 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.
More about BeiGene Ltd
Average Trading Volume: 6,485,762
Technical Sentiment Signal: Buy
Current Market Cap: HK$329.8B
For detailed information about 6160 stock, go to TipRanks’ Stock Analysis page.